Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-1998 | 03-1997 | 03-1996 | 03-1995 | 03-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 2,289 | 1,809 | 1,219 | 2,031 |
| Marketable Securities | 0 | 0 | 1,029 | 416 | 0 |
| Receivables | 0 | 2,329 | 2,872 | 2,126 | 1,430 |
| Inventories | 0 | 6,063 | 4,011 | 1,845 | 1,160 |
| Other current assets | 0 | 1,055 | 501 | 363 | 123 |
| TOTAL | $0 | $11,736 | $10,222 | $5,969 | $4,744 |
| Non-Current Assets | |||||
| PPE Net | 3,965 | 3,127 | 500 | 346 | 296 |
| Other Non-Current Assets | 0 | 0 | 56 | 56 | 36 |
| TOTAL | $3,965 | $3,127 | $556 | $402 | $331 |
| Total Assets | $3,965 | $15,861 | $10,778 | $6,371 | $5,075 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 399 | 514 | 284 |
| Accrued Expenses | 0 | 0 | 424 | 283 | 279 |
| TOTAL | $0 | $751 | $1,003 | $797 | $568 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $0 | $751 | $1,003 | $797 | $568 |
| Shareholders' Equity | |||||
| Common Shares | 13,100 | 12,834 | 6,791 | 6,832 | 5,875 |
| Retained earnings | 0 | 0 | 3,052 | -1,258 | -1,340 |
| Other shareholders' equity | 0 | 2,276 | -68 | 0 | -28 |
| TOTAL | $13,100 | $15,110 | $9,775 | $5,574 | $4,507 |
| Total Liabilities And Equity | $13,100 | $15,861 | $10,778 | $6,371 | $5,075 |